PTEN Loss Predicts Response to Notch Pathway Inhibition in Endometrial Cancer

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2016.04.040
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PTEN Loss of Expression Predicts Cetuximab Efficacy in Metastatic Colorectal Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2007English

PTEN Expression in Benign Human Endometrial Tissue and Cancer in Relation to Endometrial Cancer Risk Factors

Cancer Causes and Control
Cancer ResearchOncology
2015English

PTEN Loss Is a Context-Dependent Outcome Determinant in Obese and Non-Obese Endometrioid Endometrial Cancer Patients

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2015English

miR‑494‑3p Promotes the Progression of Endometrial Cancer by Regulating the PTEN/PI3K/AKT Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

New PTEN Signal Pathway in Breast Cancer

2003English

Targeting Notch Pathway Enhances Rapamycin Antitumor Activity in Pancreas Cancers Through PTEN Phosphorylation

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2011English

microRNA-21 Overexpression Contributes to Cell Proliferation by Targeting PTEN in Endometrioid Endometrial Cancer

Oncology Letters
Cancer ResearchOncology
2012English

Biomarkers Needed to Predict Progestin Response in Endometrial Cancer

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2017English

Notch Pathway Inhibition Significantly Reduces Rhabdomyosarcoma Invasiveness and Mobility in Vitro

Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy